A person's reason for using cannabis and the legal process for obtaining controlled flower are different matters. Wanting to sleep better or feel less stressed does not, by itself, establish a diagnosis, an appropriate treatment or a valid prescription.
Thailand's current medical framework requires assessment and documentation for patient access to controlled flower. Our earlier article mixed criticism of policy with instructions about legal access. This edition explains the practical distinction without suggesting that a consultation automatically legitimises every use.
What medical access involves
DTAM's establishment guidance describes prescribing by authorised professionals, indications within their professional scope and the PT 33 record. The record connects a patient, clinical reason and prescribed quantity. It is not simply a permission card to obtain any amount of any product. DTAM medical-cannabis guidance.
A responsible assessment may lead to treatment, a different treatment, further investigation or no prescription. The outcome should depend on the person and evidence, rather than on the wording of a marketing offer. Read our prescription preparation guide before booking.
Feeling a benefit is useful information, not a diagnosis
Tell the practitioner what you experienced, including unwanted effects, the preparation used and other medicines. A report of sleeping after cannabis may be relevant to a consultation, but it does not establish that cannabis treats the cause of a sleep problem or is suitable for continued use.
Ask what the treatment is intended to improve and how that improvement will be assessed. Our sleep evidence guide distinguishes immediate effects, symptoms and clinical outcomes. The same care is needed when discussing pain or anxiety.
Documentation does not replace the other rules
| Question | What needs checking |
|---|---|
| Is treatment appropriate? | An authorised professional's assessment |
| What has been prescribed? | The individual prescription and instructions |
| Who may supply it? | The establishment's relevant permission and dispensing process |
| Is the source documented? | Evidence matching the source and harvest |
| Can it be carried or used somewhere? | The separate rules for that activity and location |
The old article said every product must come from a government-certified GACP farm. That was too broad. The official sourcing notice recognises more than one route, with specific conditions. See the sourcing notice and our explanation of the accepted routes.
Likewise, PT 27, PT 28, PT 29 and PT 33 are not four interchangeable forms that every patient completes. They record different activities and responsibilities. Our records guide separates the operator's records from the patient's prescription.
Where the policy debate belongs
People can disagree about access, stigma and regulation. Those arguments should be identified as opinion and should not imply that a reader can disregard current requirements. A compassionate approach to someone seeking care can include an honest assessment and alternatives; it need not promise that all cannabis use is healing.
Historical accounts remain useful for understanding how the debate developed. Read the history of medicinal cannabis for context, while using current official documents for practical decisions.
Before arranging a consultation
Check the provider and practitioner's identity, what the fee includes and how follow-up works. Bring medical records and a medicines list. Ask how your information is handled and what happens if the practitioner does not prescribe.
A prescription is a clinical document, not blanket legal protection. Avoid services that promise guaranteed approval or universal access before they have assessed your circumstances.
Revised 6 September 2026. This practical explainer replaces the earlier blend of policy opinion, broad legal claims and guaranteed-access language.
